Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Essential Oils for Enhancing Quality of Life in ASD
NCT02543203Phase 2Completed
- Start
- Jul 2015
- Primary completion
- Mar 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) (2 arms). Primary endpoint: Pediatric Quality of Life Inventory at 28 weeks. Started Jul 2015; status: completed.
02
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02543203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02543203.